Featured Picks
Ranked by institutional buying score
$27.80
Current Price
HIMS
HealthcareHims & Hers Health Inc
Market Cap
$5.8B
P/E Ratio
145.8
Growth
+70%
Inst. Own
67%
Investment Thesis
Hims & Hers is disrupting traditional healthcare delivery through vertically integrated telemedicine platform offering treatments for sensitive conditions (hair loss, sexual health, mental health). The company owns the entire value chain from doctor consultations to pharmacy fulfillment, creating superior unit economics. Recent GLP-1 weight loss drug offering (compounded semaglutide) at 1/10th the cost of Wegovy/Ozempic represents massive TAM expansion into $100B+ obesity market. Institutional investors recognize this is not just telehealth - it's a new healthcare infrastructure play.
Under the Radar
Wall Street dismissed Hims as a 'men's ED pill company' missing the strategic transformation into comprehensive primary care platform. Stock only recently broke out after weight loss announcement. Many traditional healthcare investors overlooked the company due to DTC stigma. The business model is misunderstood - superior to traditional telemedicine because they control manufacturing, fulfillment, and distribution. Market cap of $5.8B is tiny compared to CVS ($82B) or Walgreens ($8B) despite exponentially faster growth and better margins.
$29.40
Current Price
CELH
Consumer StaplesCelsius Holdings Inc
Market Cap
$11.2B
P/E Ratio
52.3
Growth
+102%
Inst. Own
71%
Investment Thesis
Celsius is capturing energy drink market share from Red Bull and Monster with health-conscious positioning and superior distribution. Recent Pepsi partnership provides access to 1M+ retail locations. Company growing 3x faster than energy drink category overall. Institutional investors recognize this is the next $50B+ beverage brand being built in real-time, similar to Monster's rise from $5B to $60B over 15 years.
Under the Radar
Stock down 70% from 2023 peak due to inventory normalization creating buying opportunity. Wall Street overreacted to single quarter of slower growth while underlying consumer demand remains strong. Many investors missed that Pepsi distributor transition was temporary headwind, now resolved. Nielsen data shows Celsius gaining shelf space and velocity accelerating. Market underestimates international opportunity - brand only in 3 countries with 50+ targeted for expansion.
$55.20
Current Price
RYAN
FinancialsRyan Specialty Holdings Inc
Market Cap
$13.4B
P/E Ratio
42.7
Growth
+22%
Inst. Own
64%
Investment Thesis
Ryan Specialty is the largest wholesale insurance broker and underwriting manager in US, operating in highly fragmented $60B+ market. Company is Amazon of insurance - connecting retail agents with specialty carriers for complex risks traditional insurers won't cover. Recent digital platform investments creating network effects and AI-powered underwriting efficiency that competitors can't match. Institutional buying suggests market recognizes this is infrastructure play in growing specialty insurance market.
Under the Radar
Insurance broking lacks sex appeal causing many investors to overlook despite incredible business model. Stock IPO'd in 2021 at peak valuations causing initial investor fatigue. Market underestimates power of being largest player in fragmented industry with M&A consolidation tailwinds. Recent 'hard market' in insurance driving pricing power that benefits wholesale brokers disproportionately. Most investors don't understand difference between retail and wholesale broking - missing the superior economics.
$45.60
Current Price
TPB
Consumer StaplesTurning Point Brands Inc
Market Cap
$840M
P/E Ratio
12.4
Growth
+8%
Inst. Own
47%
Investment Thesis
Turning Point is evolving from traditional tobacco products into cannabinoids (CBD/Delta-9 THC) and next-gen smokeless products. Company owns leading brands in high-growth alternative nicotine segments (nicotine pouches, hemp wraps) while building cannabis CPG platform ahead of potential federal legalization. Recent institutional buying suggests recognition that this is cannabis play hidden in small-cap tobacco wrapper.
Under the Radar
Market cap under $1B excludes from major indices causing institutional underfunding. Stock trades in 'sin stock' penalty box despite pivot to healthier alternatives. Cannabis investors overlook due to tobacco heritage. Traditional tobacco investors exited during transformation. Creates orphaned stock situation despite strong fundamentals. Volume is light ($5M daily) deterring larger institutional buyers - classic underfollowed small cap setup.
$17.90
Current Price
EXPI
Real EstateeXp World Holdings Inc
Market Cap
$2.6B
P/E Ratio
24.8
Growth
+6%
Inst. Own
52%
Investment Thesis
eXp Realty is revolutionizing real estate brokerage through cloud-based model eliminating physical offices. Agent-owned cooperative structure (agents are also shareholders) creates powerful retention moat. Platform saves 70%+ on overhead vs traditional brokers while offering agents better economics. Recent institutional buying recognizes this is technology platform disrupting $100B+ brokerage industry, not just another real estate company.
Under the Radar
Real estate sector out of favor during rising rate environment masking underlying business transformation. Stock down 60% from peak despite agent count and market share growing. Many investors categorize as 'real estate' missing the technology platform story. Wall Street focused on transaction volume weakness (macro) ignoring agent recruitment strength (company-specific). Virtual-only model was controversial pre-COVID, now proven but market hasn't repriced accordingly.
$27.80
Current Price
HIMS
HealthcareHims & Hers Health Inc
Market Cap
$5.8B
P/E Ratio
145.8
Growth
+70%
Inst. Own
67%
Investment Thesis
Hims & Hers is disrupting traditional healthcare delivery through vertically integrated telemedicine platform offering treatments for sensitive conditions (hair loss, sexual health, mental health). The company owns the entire value chain from doctor consultations to pharmacy fulfillment, creating superior unit economics. Recent GLP-1 weight loss drug offering (compounded semaglutide) at 1/10th the cost of Wegovy/Ozempic represents massive TAM expansion into $100B+ obesity market. Institutional investors recognize this is not just telehealth - it's a new healthcare infrastructure play.
Under the Radar
Wall Street dismissed Hims as a 'men's ED pill company' missing the strategic transformation into comprehensive primary care platform. Stock only recently broke out after weight loss announcement. Many traditional healthcare investors overlooked the company due to DTC stigma. The business model is misunderstood - superior to traditional telemedicine because they control manufacturing, fulfillment, and distribution. Market cap of $5.8B is tiny compared to CVS ($82B) or Walgreens ($8B) despite exponentially faster growth and better margins.
$29.40
Current Price
CELH
Consumer StaplesCelsius Holdings Inc
Market Cap
$11.2B
P/E Ratio
52.3
Growth
+102%
Inst. Own
71%
Investment Thesis
Celsius is capturing energy drink market share from Red Bull and Monster with health-conscious positioning and superior distribution. Recent Pepsi partnership provides access to 1M+ retail locations. Company growing 3x faster than energy drink category overall. Institutional investors recognize this is the next $50B+ beverage brand being built in real-time, similar to Monster's rise from $5B to $60B over 15 years.
Under the Radar
Stock down 70% from 2023 peak due to inventory normalization creating buying opportunity. Wall Street overreacted to single quarter of slower growth while underlying consumer demand remains strong. Many investors missed that Pepsi distributor transition was temporary headwind, now resolved. Nielsen data shows Celsius gaining shelf space and velocity accelerating. Market underestimates international opportunity - brand only in 3 countries with 50+ targeted for expansion.
$55.20
Current Price
RYAN
FinancialsRyan Specialty Holdings Inc
Market Cap
$13.4B
P/E Ratio
42.7
Growth
+22%
Inst. Own
64%
Investment Thesis
Ryan Specialty is the largest wholesale insurance broker and underwriting manager in US, operating in highly fragmented $60B+ market. Company is Amazon of insurance - connecting retail agents with specialty carriers for complex risks traditional insurers won't cover. Recent digital platform investments creating network effects and AI-powered underwriting efficiency that competitors can't match. Institutional buying suggests market recognizes this is infrastructure play in growing specialty insurance market.
Under the Radar
Insurance broking lacks sex appeal causing many investors to overlook despite incredible business model. Stock IPO'd in 2021 at peak valuations causing initial investor fatigue. Market underestimates power of being largest player in fragmented industry with M&A consolidation tailwinds. Recent 'hard market' in insurance driving pricing power that benefits wholesale brokers disproportionately. Most investors don't understand difference between retail and wholesale broking - missing the superior economics.
$45.60
Current Price
TPB
Consumer StaplesTurning Point Brands Inc
Market Cap
$840M
P/E Ratio
12.4
Growth
+8%
Inst. Own
47%
Investment Thesis
Turning Point is evolving from traditional tobacco products into cannabinoids (CBD/Delta-9 THC) and next-gen smokeless products. Company owns leading brands in high-growth alternative nicotine segments (nicotine pouches, hemp wraps) while building cannabis CPG platform ahead of potential federal legalization. Recent institutional buying suggests recognition that this is cannabis play hidden in small-cap tobacco wrapper.
Under the Radar
Market cap under $1B excludes from major indices causing institutional underfunding. Stock trades in 'sin stock' penalty box despite pivot to healthier alternatives. Cannabis investors overlook due to tobacco heritage. Traditional tobacco investors exited during transformation. Creates orphaned stock situation despite strong fundamentals. Volume is light ($5M daily) deterring larger institutional buyers - classic underfollowed small cap setup.
$17.90
Current Price
EXPI
Real EstateeXp World Holdings Inc
Market Cap
$2.6B
P/E Ratio
24.8
Growth
+6%
Inst. Own
52%
Investment Thesis
eXp Realty is revolutionizing real estate brokerage through cloud-based model eliminating physical offices. Agent-owned cooperative structure (agents are also shareholders) creates powerful retention moat. Platform saves 70%+ on overhead vs traditional brokers while offering agents better economics. Recent institutional buying recognizes this is technology platform disrupting $100B+ brokerage industry, not just another real estate company.
Under the Radar
Real estate sector out of favor during rising rate environment masking underlying business transformation. Stock down 60% from peak despite agent count and market share growing. Many investors categorize as 'real estate' missing the technology platform story. Wall Street focused on transaction volume weakness (macro) ignoring agent recruitment strength (company-specific). Virtual-only model was controversial pre-COVID, now proven but market hasn't repriced accordingly.
Get the Complete Picture
Unlock detailed growth catalysts, comprehensive risk analysis, technical indicators, and institutional activity insights for every hidden gem.
Deep Financials
Full metric analysis
Growth Catalysts
Upcoming triggers
Risk Analysis
Know the downsides
Institutional Data
Smart money moves
Starting at $9.99/month. Cancel anytime.
Disclaimer: StockAgentPro provides AI-generated research for educational purposes only. We are not registered investment advisors. This is not financial advice. Past performance does not guarantee future results. Always do your own due diligence before making investment decisions.